# Octapharma Plasma Inc – FDA Inspection, Jun 21, 2024

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/20c3628e-157d-4277-8f4f-cf13c67065dd
Source feed: FDA_Inspections

> FDA inspection 1243162 of Octapharma Plasma Inc, June 21, 2024. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1243162
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2024-06-21
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1093062 - 2019-05-10

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/michael-a-blaine/784b203b-0a44-4f30-a4a7-1c2aa955defb)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/dfaacb62-8eba-43ef-a718-f66a1d87f355

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d